Filter
156
Filtered Results: 156
Text search:
EMA
European
Medicines
Agency
Featured
Recommendations
18
New Publications
34
Language
Document type
No document type
56
Guidelines
43
Studies & Reports
25
Fact sheets
21
Manuals
6
Situation Updates
2
Strategic & Response Plan
2
Training Material
1
Countries / Regions
Germany
7
Western and Central Europe
5
Colombia
3
Africa
3
West and Central Africa
3
East and Southern Africa
2
Eastern Europe
2
Brazil
2
Tajikistan
1
Nepal
1
Thailand
1
Kenya
1
Ukraine
1
Sierra Leone
1
Chile
1
Peru
1
Philippines
1
Guinea
1
Cambodia
1
Venezuela
1
Latin America and the Carribbean
1
Congo, Democratic Republic of
1
Paraguay
1
Denmark
1
Spain
1
Argentina
1
Bangladesh
1
Uganda
1
Russia
1
Ethiopia
1
Zambia
1
Indonesia
1
Liberia
1
Ecuador
1
India
1
Authors & Publishers
Publication Years
Category
Clinical Guidelines
32
Countries
28
Pharmacy & Technologies
6
Women & Child Health
5
Capacity Building
1
Public Health
1
Key Resources
1
Toolboxes
COVID-19
39
AMR
28
HIV
10
TB
9
Ebola
9
Pharmacy
8
Rapid Response
7
Mental Health
4
Planetary Health
4
NTDs
4
Refugee
3
Zika
2
Natural Hazards
1
Disability
1
PlosOne January 20, 2021
https://doi.org/10.1371/journal.pone.0241899
Antibiotic fixed dose combinations (FDCs) can have clinical advantages such as improving effectiveness and adherence to therapy. However, high use of potentially inappropriate FDCs has been reported, with implications for antim...
Consensual recommendations for outpatient management and home care
and home treatment of patients with COVID-19
In 2007, WHO warned that infectious diseases are emerging and re-emerging at a rate that has not been seen before. The potential for infectious diseases to spread rapidly results in high morbidity and mortality, causing a potential global public health treat of major concern.
Several factors are ...
The International Pharmaceutical Federation (FIP) is a global federation of national associations of pharmacists and
pharmaceutical scientists. In order to support these associations in their fight against AMR, FIP has prepared this
briefing document. It is an overview of the different activities ...
These guidelines provide updated evidence-based recommendations on the priority HCV-related topics from the 2018 WHO Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C infection and the 2017 WHO Guidelines on hepatitis B and C testing. These priority areas are:
...
Several Public Health Services and general practitioners in the Netherlands observed an increase in scabies in the Netherlands. Since individual cases of scabies are not notifiable in the Netherlands, the epidemiological situation is mostly unknown. To investigate the scabies incidence in the Nether...
16-17 march 2015, Geneva, Switzerland
Meeting report
Principles and Target Product Criteria. Roadmap January 12, 2015
The systematic surveillance of antibiotic use and antibiotic re-sistance prevalence in humans and animals is imperative for managingbacterial infectious disease (JPIAMR, 2019;WHO, 2015). Many low-income countries currently face substantial challenges in building national surveillance systems due to ...
This report presents an analysis of antibacterial agents in preclinical (third annual review) and clinical (fifth annual review) development. The analysis covers traditional (direct-acting small molecules) and non-traditional antibacterial agents in development worldwide. It evaluates to what extent...
This publication describes an arduous campaign to tackle the use of antimicrobials - specifically antibiotics - in the Danish swine-producing sector thanks to the collaboration between the regulatory sector within the Ministry of Environment and Food, private veterinary practitioners and swine produ...
Drugs, Diagnostics, Vaccines, Preventive Technologies, Research toward a cure, and immune-based and gene therapies in development
The use of Delamanid and Bedaquiline for Children with Drug-Resistant Tuberculosis.
